Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: A retrospective study
Số trang: 9
Loại file: pdf
Dung lượng: 1.48 MB
Lượt xem: 8
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
S-1 adjuvant chemotherapy is the standard treatment in Asia for resectable pancreatic ductal adenocarcinoma. The relative dose intensity of adjuvant chemotherapy influences survival in pancreatic cancer but does not precisely reflect treatment schedule modifications. We investigated the effects of total dose intensity of S-1 adjuvant chemotherapy on the survival of patients with pancreatic cancer and the permissible dose reduction.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Pancreatic cancer Adjuvant chemotherapy Total dose intensity Relative dose intensity S-1 adjuvant chemotherapyGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 119 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
11 trang 37 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0 -
13 trang 36 0 0
-
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
9 trang 34 0 0 -
Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image
10 trang 34 0 0 -
11 trang 33 0 0
-
9 trang 33 0 0
-
The History of Sound in the Cinema
5 trang 33 0 0 -
CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: A case-control study
14 trang 32 0 0 -
SALSA: Analyzing Logs as StAte Machines
8 trang 32 0 0 -
11 trang 32 0 0